Substantial reduction of basal cell carcinoma tumor size with itraconazole following treatment failure with intralesional 5-fluorouracil

被引:0
|
作者
Patil, Nitin Krishna [1 ]
Bubna, Aditya Kumar [1 ,2 ]
机构
[1] Katihar Med Coll, Dept Dermatol, Katihar, Bihar, India
[2] Katihar Med Coll, Dept Dermatol, Katihar 854106, Bihar, India
来源
关键词
HEDGEHOG PATHWAY;
D O I
10.4103/jewd.jewd_31_22
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:60 / 62
页数:3
相关论文
共 50 条
  • [41] Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis
    Neale, Holly
    Michelon, Melissa
    Jacob, Susan
    Pinkston, Mary
    Ukaegbu, Rebecca
    Zamor, Waldo
    Morrison, Emily
    Deng, April
    Levin, Nikki A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (02) : 423 - 425
  • [42] Strontium-90 brachytherapy following intralesional triamcinolone and 5-fluorouracil injections for keloid treatment: A randomized controlled trial
    Deng, Ke
    Xiao, Haitao
    Liu, Xiaoxue
    Ogawa, Rei
    Xu, Xuewen
    Liu, Yong
    PLOS ONE, 2021, 16 (03):
  • [43] Combination of 5-fluorouracil and cryotherapy in the treatment of multiple superficial basal cell carcinomas located on the trunk
    Aydin, Fatma
    Senturk, Nilgun
    Yildiz, Levent
    Koca, Rafet
    Canturk, Tayyar
    Yalin, Turkay
    Turanli, Ahmet Yasar
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2006, 40 (02): : 66 - 68
  • [44] TUMORS OF SKIN .6. STUDY ON EFFECTS OF LACAL ADMINISTRATION OF 5-FLUOROURACIL IN BASAL CELL CARCINOMA
    KLEIN, E
    STOLL, HL
    MILGROM, H
    TRAENKLE, HL
    GRAHAM, S
    HELM, F
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1966, 47 (01) : 22 - &
  • [45] New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid
    Cappugi, P
    Mavilia, L
    Campolmi, P
    Reali, EF
    Mori, M
    Rossi, R
    JOURNAL OF CHEMOTHERAPY, 2004, 16 (05) : 491 - 493
  • [46] 5-fluorouracil 5% cream for squamous cell carcinoma in situ: Factors impacting treatment response
    Lin, Christine P.
    Kibbi, Nour
    Bandali, Tarek
    Hirotsu, Kelsey
    Aasi, Sumaira Z.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (03) : 473 - 479
  • [47] Substantial activity of budesonide in patients with irinotecan (CPT-11) and 5-fluorouracil induced diarrhea and failure of loperamide treatment
    Lenfers, BHM
    Loeffler, TM
    Droege, CM
    Hausamen, TU
    ANNALS OF ONCOLOGY, 1999, 10 (10) : 1251 - 1253
  • [48] Treatment of corneal squamous cell carcinoma using topical 1% 5-fluorouracil as monotherapy
    Dorbandt, Daniel M.
    Driskell, Elizabeth A.
    Hamor, Ralph E.
    VETERINARY OPHTHALMOLOGY, 2016, 19 (03) : 256 - 261
  • [49] TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE SKIN WITH CISPLATIN, 5-FLUOROURACIL, AND BLEOMYCIN
    SADEK, H
    AZLI, N
    WENDLING, JL
    CVITKOVIC, E
    RAHAL, M
    MAMELLE, G
    GUILLAUME, JC
    ARMAND, JP
    AVRIL, MF
    CANCER, 1990, 66 (08) : 1692 - 1696
  • [50] Risk of keratinocyte carcinoma following field treatment of actinic keratoses with 5-fluorouracil versus imiquimod
    Levandoski, Katherine
    Neugebauer, Romain
    Zhu, Zheng
    Sokil, Monica
    Chren, Mary-Margaret
    Friedman, Gary
    Asgari, Maryam
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB247 - AB247